Drug Database
Back to search

Poland· PL-100478930

Bulgaplin

A pregabalin product containing pregabalinum, registered in Poland by Orion Corporation. The same ATC class is registered in 3 of our 19 countries.

ATC N03AX16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBulgaplinATCN03AX16REGISTER NO.PL-100478930PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pregabalinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pregabalin is registered in 3 of 19 countries.

Countries holding a registration under ATC N03AX16 (pregabalin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search pregabalin products by name

Pregabalin · ATC N03AX16

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pregabalinum
Manufacturer
Orion Corporation
Country
Poland (PL)
ATC code
N03AX16
ATC class
Pregabalin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991536626

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

282 interactions on record for pregabalin.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pregabalin against other medicinesHow interaction checks work

Pregabalin · interactions on record

282 records

  • 4 severe
  • 60 moderate
  • 180 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

38 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pregabalin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pregabalin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lynagex, Lynagex 165 Mg
  • Belgium · Lynagex, Pregabalin Ab
  • Bulgaria · Pregabin, Бриека
  • Cyprus · Epibal, Grabilen
  • Czechia · Kartesada, Naxalgan
  • Germany · Pregabador, Pregabahexal
  • Denmark · Galberin, Lyribastad
  • Estonia · Brieka, Bulgaplin
  • Spain · Aciryl, Apregia
  • Finland · Lyribastad, Pregabalin Grindeks
  • France · Lexenu, Lexenu 75 Mg
  • United Kingdom (Northern Ireland) · Alzain, Avellar
  • Greece · Algecia, Apregalin
  • Croatia · Pragiola, Pregabalin Belupo
  • Hungary · Kartesada, Naxalgan
  • Ireland · Pregabalin Basics, Pregabalin Brillpharma (Ireland)
  • Iceland · Brieka, Lyrica
  • Italy · Aclaton, Ecubalin
  • Liechtenstein · Lyrica, Pregabalin Accord
  • Lithuania · Brieka, Bulgaplin
  • Luxembourg · Pregabalin Micro Labs, Pregabaline Eg
  • Latvia · Brieka, Bulgaplin
  • Malta · Epibal, Pragiola
  • Netherlands · Dalingo, Linefor
  • Norway · Lyrica, Pregabalin 1a Farma
  • Portugal · Kartesada, Lygabrin
  • Romania · Lynagex, Pragiola
  • Sweden · Brieka, Bulgaplin
  • Slovenia · Pragiola, Pregabalin Grindeks
  • Slovakia · Kartesada, Naxalgan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8590fef-86b8-44cd-9fbf-5865a066b29a
GET /v1/drugs/d8590fef-86b8-44cd-9fbf-5865a066b29a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "300 mg",
  "packaging": "05909991536626 ¦ Rp ¦ 153928\n1 blister 56 kaps.",
  "substance": "Pregabalinum 300 mg",
  "common_name": "Pregabalinum",
  "pl_product_id": "100478930",
  "pozwolenie_nr": "28244",
  "auth_procedure": "DCP",
  "authorisation_validity": "2029-03-27"
}
API referenceMCP serverPlans

See everything about pregabalin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console